BioLionaire Scientist—Volume 3: RNA EMPIRE: The Business of RNA Platforms Turning RNA Into Scalable Enterprises

RNA Empire examines the transformation of RNA from a molecular intermediary into one of the most powerful therapeutic platforms in modern biotechnology.

From messenger RNA vaccines to gene silencing technologies, aptamers, circular RNA, and the convergence of CRISPR with RNA systems, this volume explores how RNA became programmable infrastructure. It analyzes the scientific breakthroughs that made RNA medicines possible, the delivery systems that enabled clinical translation, and the platform strategies that turned RNA into a scalable enterprise.

Rather than presenting RNA as a single technological wave, this book frames it as an ecosystem — where molecular engineering, lipid nanoparticle delivery, manufacturing scalability, regulatory navigation, and funding strategy determine long-term dominance.

Written for scientists, translational researchers, founders, and biotech strategists, RNA Empire connects mechanism with monetization and discovery with durable platform building.

Who This Book Is For This volume is written for graduate students, postdoctoral researchers, clinician-scientists, RNA biologists, biotech founders, translational teams, and innovation-driven institutions seeking a rigorous understanding of RNA platform strategy. It is also appropriate for academic libraries and biotechnology incubators focused on next-generation therapeutics.

Table of Contents Part I - The Science of RNA
Chapter 1 — RNA: The Unsung Architect of Life
Chapter 2 — The RNA Toolbox
Chapter 3 — How mRNA Became a Medicine

Part II - RNA Therapeutics
Chapter 4 — RNA Delivery Systems
Chapter 5 — mRNA Therapeutics: Vaccines & Beyond
Chapter 6 — mRNA Interference & Gene Silencing
Chapter 7 — Aptamers: The Nucleic-Acid Antibodies
Chapter 8 — CRISPR Meets RNA
Chapter 9 — Cell-Free RNA Manufacturing
Chapter 10— Circular RNA & Next-Gen RNA Drugs

Part III - RNA Industry
Chapter 11 — RNA-Based Therapeutic Platforms
Chapter 12 — BioLionaire Roadmap in the RNA Age

Appendices
Appendix A — NIH SBIR Phase I Proposal Roadmap
Appendix B — Example (II) SBIR Phase I Grant Proposal

Glossary
Index
Companies Discussed in this Volume
Essential Reading